News
-
-
-
-
-
-
-
-
PRESS RELEASE
Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Onco-Innovations completes successful 300g scale-up batch of A83B4C63, achieving 99.3% purity for API under ONC010 PNKP Inhibitor Technology. Dave Antony appointed as CFO -
-